A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.
Abstract | BACKGROUND: Risk factor identification is a proven strategy in advancing treatments and preventive therapy for many chronic conditions. Quantifying the impact of those risk factors on health outcomes can consolidate and focus efforts on individuals with specific high-risk profiles. Using multiple risk factors and longitudinal outcomes in 2 independent cohorts, we developed and validated a risk score model to predict mortality in current and former cigarette smokers. METHODS: We obtained extensive data on current and former smokers from the COPD Genetic Epidemiology (COPDGene®) study at enrollment. Based on physician input and model goodness-of-fit measures, a subset of variables was selected to fit final Weibull survival models separately for men and women. Coefficients and predictors were translated into a point system, allowing for easy computation of mortality risk scores and probabilities. We then used the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort for external validation of our model. RESULTS: Of 9867 COPDGene participants with standard baseline data, 17.6% died over 10 years of follow-up, and 9074 of these participants had the full set of baseline predictors (standard plus 6-minute walk distance and computed tomography variables) available for full model fits. The average age of participants in the cohort was 60 for both men and women, and the average predicted 10-year mortality risk was 18% for women and 25% for men. Model time-integrated area under the receiver operating characteristic curve statistics demonstrated good predictive model accuracy (0.797 average), validated in the external cohort (0.756 average). Risk of mortality was impacted most by 6-minute walk distance, forced expiratory volume in 1 second and age, for both men and women. CONCLUSIONS:
|
Authors | Matthew Strand, Erin Austin, Matthew Moll, Katherine A Pratte, Elizabeth A Regan, Lystra P Hayden, Surya P Bhatt, Aladin M Boriek, Richard Casaburi, Edwin K Silverman, Spyridon Fortis, Ingo Ruczinski, Harald Koegler, Harry B Rossiter, Mariaelena Occhipinti, Nicola A Hanania, Hirut T Gebrekristos, David A Lynch, Ken M Kunisaki, Kendra A Young, Jessica C Sieren, Margaret Ragland, John E Hokanson, Sharon M Lutz, Barry J Make, Gregory L Kinney, Michael H Cho, Massimo Pistolesi, Dawn L DeMeo, Frank C Sciurba, Alejandro P Comellas, Alejandro A Diaz, Igor Barjaktarevic, Russell P Bowler, Richard E Kanner, Stephen P Peters, Victor E Ortega, Mark T Dransfield, James D Crapo |
Journal | Chronic obstructive pulmonary diseases (Miami, Fla.)
(Chronic Obstr Pulm Dis)
Vol. 7
Issue 4
Pg. 346-361
(Oct 2020)
ISSN: 2372-952X [Print] United States |
PMID | 32877963
(Publication Type: Journal Article)
|
Copyright | JCOPDF © 2020. |
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|